Matarin Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $3.26M | Sell |
129,607
-59,271
| -31% | -$1.49M | 0.8% | 43 |
|
|
2020
Q3 | $3.94M | Sell |
188,878
-27,865
| -13% | -$581K | 0.83% | 41 |
|
|
2020
Q2 | $5.15M | Sell |
216,743
-171,242
| -44% | -$4.07M | 1.03% | 17 |
|
|
2020
Q1 | $6.98M | Sell |
387,985
-21,923
| -5% | -$394K | 1.08% | 11 |
|
|
2019
Q4 | $9.72M | Sell |
409,908
-13,322
| -3% | -$316K | 0.93% | 21 |
|
|
2019
Q3 | $11.6M | Buy |
423,230
+305,082
| +258% | +$8.38M | 0.88% | 36 |
|
|
2019
Q2 | $3.91M | Buy |
+118,148
| New | +$3.91M | 0.28% | 133 |
|